Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives

Gastroenteropancreatic neuroendocrine tumours (GEP NETs) are rare tumours that present many clinical features. They secrete peptides and neuroamines that cause distinct clinical syndromes, including carcinoid syndrome. However, many are clinically silent until late presentation with mass effects. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Appetecchia, Marialuisa, Baldelli, Roberto
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845555/
https://www.ncbi.nlm.nih.gov/pubmed/20196864
http://dx.doi.org/10.1186/1756-9966-29-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845555/
https://www.ncbi.nlm.nih.gov/pubmed/20196864
http://dx.doi.org/10.1186/1756-9966-29-19

Ejemplares similares